Skip to main content
Back
Watch Compare

NovaBridge Biosciences

Data quality: 83%
NBP
Nasdaq Manufacturing Chemicals
$2.41
▼ $0.04 (-1.63%)
Mkt Cap: 277.85 M
Price
$2.41
Mkt Cap
277.85 M
Day Range
$2.27 — $2.46
52-Week Range
$0.63 — $6.79
Volume
422,517
Open $2.40
50D / 200D Avg
$3.15
23.53% below
50D / 200D Avg
$3.66
34.10% below

Quick Summary

Key Takeaways

Revenue declined -53.75% annually over 5 years
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 53.75%
Capital efficient — spends only 1.11% of revenue on capex

Growth

Revenue Growth (5Y)
-53.75%
Below sector avg (1.82%)
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-20.31%
Above sector avg (-53.41%)
ROIC-32.33%
Net Margin-7321.04%
Op. Margin-14915.98%

Safety

Debt / Equity
N/A
Current Ratio14.47
Interest CoverageN/A

Valuation

PE (TTM)
-6.01
Below sector avg (-1.48)
P/B Ratio1.07
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -6.0 -1.5
P/B 1.1 1.6
ROE % -20.3 -53.4
Net Margin % -7321.0 -41.5
Rev Growth 5Y % -53.8 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) -59.71%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -53.75% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 632,000.0 Net Income (TTM) -46.27 M
ROE -20.31% ROA -19.11%
Gross Margin N/A Operating Margin -14915.98%
Net Margin -7321.04% Free Cash Flow (TTM) N/A
ROIC -32.33% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 14.47
Interest Coverage N/A Asset Turnover 0.00
Working Capital 216.68 M Tangible Book Value 258.92 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.01 Forward P/E N/A
P/B Ratio 1.07 P/S Ratio 439.64
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 277.85 M Enterprise Value 49.79 M
Per Share
EPS (Diluted TTM) -0.21 Revenue / Share 0.01
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.11% FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum 53.75

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 632,000.0 632,000.0 3.89 M -32.12 M 13.81 M
Net Income -46.27 M -22.23 M -206.44 M -363.53 M -365.87 M
EPS (Diluted) -0.21 -0.12 -1.08 -1.92 -2.09
Gross Profit — — — — —
Operating Income -94.27 M -51.43 M — — —
EBITDA — — — — —
R&D Expenses 62.91 M 21.77 M 114.18 M 131.20 M 190.34 M
SG&A Expenses — — — — —
D&A — 300,000.0 3.40 M 3.70 M —
Interest Expense — — 102,000.0 1,000.0 0.0
Income Tax 0.0 0.0 — 101,000.0 -495,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 260.52 M 212.68 M 368.03 M 590.63 M 878.95 M
Total Liabilities 29.58 M 11.52 M 126.03 M 168.73 M 163.45 M
Shareholders' Equity 230.94 M 201.16 M 242.00 M 421.90 M 715.50 M
Total Debt — — 4.22 M 2.75 M —
Cash & Equivalents 210.63 M 68.26 M 301.62 M 465.99 M 552.94 M
Current Assets 217.52 M 176.69 M 329.11 M 525.79 M 750.36 M
Current Liabilities 26.89 M 8.45 M 58.00 M 109.92 M 97.92 M